Annual EBITDA
-$3.38 M
-$4.51 M-399.65%
31 December 2023
Summary:
STRATA Skin Sciences annual earnings before interest, taxes, depreciation & amortization is currently -$3.38 million, with the most recent change of -$4.51 million (-399.65%) on 31 December 2023. During the last 3 years, it has fallen by -$3.37 million (-22433.33%). SSKN annual EBITDA is now -174.50% below its all-time high of $4.54 million, reached on 31 December 2017.SSKN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$265.00 K
-$2.03 M-115.05%
30 September 2024
Summary:
STRATA Skin Sciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$265.00 thousand, with the most recent change of -$2.03 million (-115.05%) on 30 September 2024. Over the past year, it has dropped by -$1.28 million (-126.16%). SSKN quarterly EBITDA is now -112.78% below its all-time high of $2.07 million, reached on 30 June 2021.SSKN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$1.99 M
-$1.28 M-179.24%
30 September 2024
Summary:
STRATA Skin Sciences TTM earnings before interest, taxes, depreciation & amortization is currently -$1.99 million, with the most recent change of -$1.28 million (-179.24%) on 30 September 2024. Over the past year, it has dropped by -$2.25 million (-883.86%). SSKN TTM EBITDA is now -133.90% below its all-time high of $5.87 million, reached on 30 June 2017.SSKN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SSKN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -399.6% | -126.2% | -883.9% |
| 3 y3 years | -10000.0% | -143.7% | -205.5% |
| 5 y5 years | -265.5% | -158.4% | -204.2% |
SSKN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -295.6% | at low | -115.0% | +86.7% | -186.6% | +48.1% |
| 5 y | 5 years | -265.5% | at low | -112.8% | +86.7% | -186.6% | +48.1% |
| alltime | all time | -174.5% | +85.3% | -112.8% | +97.0% | -133.9% | +91.9% |
STRATA Skin Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$265.00 K(-115.0%) | -$1.99 M(+179.2%) |
| June 2024 | - | $1.76 M(-217.4%) | -$713.00 K(-81.4%) |
| Mar 2024 | - | -$1.50 M(-24.5%) | -$3.83 M(+13.4%) |
| Dec 2023 | -$3.38 M(-399.6%) | -$1.99 M(-296.2%) | -$3.38 M(-1430.7%) |
| Sept 2023 | - | $1.01 M(-174.5%) | $254.00 K(-292.4%) |
| June 2023 | - | -$1.36 M(+29.8%) | -$132.00 K(-113.6%) |
| Mar 2023 | - | -$1.05 M(-163.6%) | $974.00 K(-13.7%) |
| Dec 2022 | $1.13 M(-34.7%) | $1.65 M(+162.7%) | $1.13 M(<-9900.0%) |
| Sept 2022 | - | $627.00 K(-347.8%) | -$5000.00(-80.8%) |
| June 2022 | - | -$253.00 K(-71.7%) | -$26.00 K(-101.1%) |
| Mar 2022 | - | -$893.00 K(-273.7%) | $2.30 M(+33.1%) |
| Dec 2021 | $1.73 M(<-9900.0%) | $514.00 K(-15.2%) | $1.73 M(-8.5%) |
| Sept 2021 | - | $606.00 K(-70.8%) | $1.89 M(+86.7%) |
| June 2021 | - | $2.07 M(-241.5%) | $1.01 M(-161.3%) |
| Mar 2021 | - | -$1.47 M(-317.4%) | -$1.65 M(>+9900.0%) |
| Dec 2020 | -$15.00 K(-100.8%) | $674.00 K(-348.7%) | -$15.00 K(-103.8%) |
| Sept 2020 | - | -$271.00 K(-53.8%) | $398.00 K(-64.6%) |
| June 2020 | - | -$587.00 K(-447.3%) | $1.12 M(-41.6%) |
| Mar 2020 | - | $169.00 K(-84.5%) | $1.92 M(+6.2%) |
| Dec 2019 | $1.81 M(-11.3%) | $1.09 M(+139.4%) | $1.81 M(-5.2%) |
| Sept 2019 | - | $454.00 K(+112.1%) | $1.91 M(-20.0%) |
| June 2019 | - | $214.00 K(+282.1%) | $2.39 M(+2.4%) |
| Mar 2019 | - | $56.00 K(-95.3%) | $2.33 M(+14.4%) |
| Dec 2018 | $2.04 M(-55.0%) | $1.19 M(+27.3%) | $2.04 M(+33.3%) |
| Sept 2018 | - | $932.00 K(+486.2%) | $1.53 M(-6.0%) |
| June 2018 | - | $159.00 K(-167.1%) | $1.63 M(-52.7%) |
| Mar 2018 | - | -$237.00 K(-135.1%) | $3.44 M(-24.1%) |
| Dec 2017 | $4.54 M(+63.8%) | $676.00 K(-34.4%) | $4.54 M(-21.6%) |
| Sept 2017 | - | $1.03 M(-47.8%) | $5.79 M(-1.5%) |
| June 2017 | - | $1.98 M(+130.7%) | $5.87 M(+44.0%) |
| Mar 2017 | - | $856.00 K(-55.6%) | $4.08 M(+47.3%) |
| Dec 2016 | $2.77 M(-122.3%) | $1.93 M(+72.6%) | $2.77 M(+168.6%) |
| Sept 2016 | - | $1.12 M(+516.6%) | $1.03 M(-247.1%) |
| June 2016 | - | $181.00 K(-139.9%) | -$701.00 K(-92.7%) |
| Mar 2016 | - | -$454.00 K(-341.5%) | -$9.56 M(-23.0%) |
| Dec 2015 | -$12.42 M(-16.2%) | $188.00 K(-130.5%) | -$12.42 M(-21.5%) |
| Sept 2015 | - | -$616.00 K(-92.9%) | -$15.82 M(-15.5%) |
| June 2015 | - | -$8.68 M(+161.8%) | -$18.72 M(+32.6%) |
| Mar 2015 | - | -$3.32 M(+3.2%) | -$14.11 M(-21.9%) |
| Dec 2014 | -$14.83 M | -$3.21 M(-8.5%) | -$18.08 M(-4.0%) |
| Sept 2014 | - | -$3.51 M(-13.8%) | -$18.83 M(-13.7%) |
| June 2014 | - | -$4.07 M(-44.1%) | -$21.82 M(-10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$7.28 M(+83.9%) | -$24.26 M(+5.7%) |
| Dec 2013 | -$22.95 M(+5.7%) | -$3.96 M(-39.1%) | -$22.95 M(-6.9%) |
| Sept 2013 | - | -$6.50 M(-0.3%) | -$24.63 M(+6.0%) |
| June 2013 | - | -$6.52 M(+9.3%) | -$23.25 M(+5.5%) |
| Mar 2013 | - | -$5.97 M(+5.6%) | -$22.05 M(+1.7%) |
| Dec 2012 | -$21.70 M(+9.1%) | -$5.65 M(+10.4%) | -$21.68 M(+6.2%) |
| Sept 2012 | - | -$5.12 M(-3.8%) | -$20.43 M(-4.1%) |
| June 2012 | - | -$5.32 M(-5.2%) | -$21.31 M(+3.0%) |
| Mar 2012 | - | -$5.61 M(+27.7%) | -$20.68 M(+3.9%) |
| Dec 2011 | -$19.90 M(+1.1%) | -$4.39 M(-26.8%) | -$19.90 M(-5.1%) |
| Sept 2011 | - | -$6.00 M(+27.8%) | -$20.96 M(+5.9%) |
| June 2011 | - | -$4.69 M(-2.7%) | -$19.79 M(+1.1%) |
| Mar 2011 | - | -$4.82 M(-11.5%) | -$19.57 M(-0.6%) |
| Dec 2010 | -$19.68 M(+7.7%) | -$5.45 M(+12.9%) | -$19.68 M(-0.3%) |
| Sept 2010 | - | -$4.83 M(+8.0%) | -$19.74 M(-0.8%) |
| June 2010 | - | -$4.47 M(-9.5%) | -$19.90 M(+3.5%) |
| Mar 2010 | - | -$4.94 M(-10.3%) | -$19.22 M(+5.2%) |
| Dec 2009 | -$18.27 M(+1.7%) | -$5.50 M(+10.2%) | -$18.27 M(+7.4%) |
| Sept 2009 | - | -$4.99 M(+31.8%) | -$17.00 M(+4.3%) |
| June 2009 | - | -$3.79 M(-4.8%) | -$16.30 M(-7.0%) |
| Mar 2009 | - | -$3.98 M(-6.1%) | -$17.53 M(-2.4%) |
| Dec 2008 | -$17.97 M(+39.6%) | -$4.24 M(-1.1%) | -$17.97 M(+4.8%) |
| Sept 2008 | - | -$4.29 M(-14.6%) | -$17.14 M(+8.3%) |
| June 2008 | - | -$5.02 M(+13.6%) | -$15.82 M(+12.4%) |
| Mar 2008 | - | -$4.42 M(+29.5%) | -$14.07 M(+9.4%) |
| Dec 2007 | -$12.87 M(+7.6%) | -$3.41 M(+14.9%) | -$12.87 M(+0.9%) |
| Sept 2007 | - | -$2.97 M(-9.2%) | -$12.76 M(+3.5%) |
| June 2007 | - | -$3.27 M(+1.7%) | -$12.33 M(+2.4%) |
| Mar 2007 | - | -$3.22 M(-2.7%) | -$12.03 M(+1.4%) |
| Dec 2006 | -$11.96 M(+85.7%) | -$3.30 M(+30.2%) | -$11.87 M(+6.9%) |
| Sept 2006 | - | -$2.54 M(-14.8%) | -$11.10 M(+11.9%) |
| June 2006 | - | -$2.98 M(-2.4%) | -$9.93 M(+18.9%) |
| Mar 2006 | - | -$3.05 M(+20.4%) | -$8.35 M(+57.6%) |
| Dec 2005 | -$6.44 M(+107.8%) | -$2.54 M(+86.4%) | -$5.30 M(+34.8%) |
| Sept 2005 | - | -$1.36 M(-2.9%) | -$3.93 M(+23.0%) |
| June 2005 | - | -$1.40 M(+20.1%) | -$3.19 M(+78.1%) |
| Dec 2004 | -$3.10 M(+66.5%) | -$1.17 M(+86.4%) | -$1.79 M(+186.4%) |
| Sept 2004 | - | -$626.10 K | -$626.10 K |
| Dec 2003 | -$1.86 M(+103.5%) | - | - |
| Dec 2002 | -$915.00 K(-66.2%) | - | - |
| Dec 2001 | -$2.71 M(+48.3%) | - | - |
| Dec 2000 | -$1.82 M | - | - |
FAQ
- What is STRATA Skin Sciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for STRATA Skin Sciences?
- What is STRATA Skin Sciences annual EBITDA year-on-year change?
- What is STRATA Skin Sciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for STRATA Skin Sciences?
- What is STRATA Skin Sciences quarterly EBITDA year-on-year change?
- What is STRATA Skin Sciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for STRATA Skin Sciences?
- What is STRATA Skin Sciences TTM EBITDA year-on-year change?
What is STRATA Skin Sciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SSKN is -$3.38 M
What is the all time high annual EBITDA for STRATA Skin Sciences?
STRATA Skin Sciences all-time high annual earnings before interest, taxes, depreciation & amortization is $4.54 M
What is STRATA Skin Sciences annual EBITDA year-on-year change?
Over the past year, SSKN annual earnings before interest, taxes, depreciation & amortization has changed by -$4.51 M (-399.65%)
What is STRATA Skin Sciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of SSKN is -$265.00 K
What is the all time high quarterly EBITDA for STRATA Skin Sciences?
STRATA Skin Sciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $2.07 M
What is STRATA Skin Sciences quarterly EBITDA year-on-year change?
Over the past year, SSKN quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.28 M (-126.16%)
What is STRATA Skin Sciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of SSKN is -$1.99 M
What is the all time high TTM EBITDA for STRATA Skin Sciences?
STRATA Skin Sciences all-time high TTM earnings before interest, taxes, depreciation & amortization is $5.87 M
What is STRATA Skin Sciences TTM EBITDA year-on-year change?
Over the past year, SSKN TTM earnings before interest, taxes, depreciation & amortization has changed by -$2.25 M (-883.86%)